Does EVOLOCUMAB Cause Gait inability? 206 Reports in FDA Database

Q: Does EVOLOCUMAB cause Gait inability?

206 reports of Gait inability have been filed with the FDA for EVOLOCUMAB, representing 0.1% of all EVOLOCUMAB adverse event reports.

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 206 reports of Gait inability have been filed in association with EVOLOCUMAB (REPATHA). This represents 0.1% of all adverse event reports for EVOLOCUMAB.

206

Reports of Gait inability with EVOLOCUMAB

0.1%

of all EVOLOCUMAB reports

Deaths

Hospitalizations

How Dangerous Is Gait inability From EVOLOCUMAB?

Of the 206 reports, 25 (12.1%) required hospitalization, and 1 (0.5%) were considered life-threatening.

Is Gait inability Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EVOLOCUMAB. However, 206 reports have been filed with the FAERS database.

What Other Side Effects Does EVOLOCUMAB Cause?

Device difficult to use (31,807) Drug dose omission by device (23,957) Wrong technique in product usage process (21,664) Accidental exposure to product (16,160) Injection site pain (9,988) Product storage error (6,606) Back pain (5,254) Myalgia (5,061) Drug dose omission (4,914) Injection site bruising (4,409)

What Other Drugs Cause Gait inability?

ADALIMUMAB (3,844) ETANERCEPT (2,710) METHOTREXATE (2,559) TOFACITINIB (2,227) SECUKINUMAB (2,216) TOCILIZUMAB (2,139) LEFLUNOMIDE (2,065) RITUXIMAB (2,028) ABATACEPT (2,019) HYDROXYCHLOROQUINE (1,881)

Which EVOLOCUMAB Alternatives Have Lower Gait inability Risk?

EVOLOCUMAB vs EXELON EVOLOCUMAB vs EXEMESTANE EVOLOCUMAB vs EXENATIDE EVOLOCUMAB vs EXFORGE EVOLOCUMAB vs EXJADE

EVOLOCUMAB Full Profile All Gait inability Reports All Drugs Causing Gait inability EVOLOCUMAB Demographics